CXXIFC21 Investments Inc.
Price Chart
Loading chart...
About C21 Investments Inc. (CXXIF)
C21 Investments Inc. (CXXIF) is a Drug Manufacturers - Specialty & Generic company headquartered in Vancouver, BC, Canada whose shares trade over-the-counter on the OTCQX tier.
C21 Investments Inc. is a vertically integrated cannabis company that cultivates, processes, and distributes quality cannabis and hemp-derived consumer products in the United States. The Company is focused on value creation through the disciplined acquisition and integration of core retail, manufacturing, and distribution assets in strategic markets, leveraging industry-leading retail revenues with high-growth potential multi-market branded consumer packaged goods.
Products and services
The company produces products in the health sciences sector, and sells them in its own retail stores and wholesales to third party retail stores.
CXXIF key facts
- Ticker symbol
- CXXIF
- Market tier
- OTCQX
- Sector
- Healthcare
- Headquarters
- Vancouver, BC, Canada
- Country of incorporation
- CA
- Year of incorporation
- 1987
- Employees
- 136
- Estimated market cap
- $15.10M (as of Apr 9, 2025)
- Shares outstanding
- 117,996,814
- Reporting standard
- U.S. Reporting: SEC Reporting
- Audit status
- Audited
- Fiscal year end
- 3/31
C21 Investments Inc. leadership
- Sonny Newman — CEO, President
- Aron Swan — COO
- Michael Kidd — CFO, Secretary
- Jaide McGee — Corporate Controller
- Salvator Armenia — IR
Explore more: Drug Manufacturers - Specialty & Generic stocks · Healthcare sector · OTCQX stocks · OTC stocks starting with C
Press Releases
Loading press releases...
Latest News
Loading news...
Key Statistics
Major Holders
Loading...
Loading modules...
AI-Powered Stock Analysis
Get a concise 600-word investment analysis for C21 Investments Inc. (CXXIF) prioritizing the most recent news and developments. Our AI focuses on today's breaking news first, then recent company developments, business updates, strategic initiatives, and current market positioning. Get the most relevant and current analysis available.
Still in beta - Please send feedback after generating your analysis to help us improve!
Smart investment analysis prioritizing breaking news, then recent company developments and strategic insights - completely free!
More Drug Manufacturers - Specialty & Generic Companies on OTC Markets
Other OTC-traded companies in Drug Manufacturers - Specialty & Generic:
Investor Reviews
Investor Reviews (0)
Loading reviews...
Company Profile
Loading company profile data...
Contact Information
Company Leadership
Company Officers
Social Media
Business Details
Stock Details
Loading modules...